Health Research BC 2024 Suite of Funding Programs

Health Research BC 2024 Suite of Funding Programs

The 2024 suite of funding programs through Michael Smith Health Research BC has been announced.

Collectively, these programs provide BC health researchers with funding awards to help develop, retain and attract the people whose research significantly improves the health of British Columbians.

Learn about these programs below and stay tuned for more information!

Applications Opening October 2023

Supports health professionals who are actively involved in patient care to build their health research programs.

Supports early career health researchers, helping them form their own research teams, train the next generation of scientists, and develop world-leading research programs.

Applications Opening November 2023

Supports the best and brightest health researchers in training to enable career development and support world-class health research in BC.

Applications Opening April 2024

Supports teams of health researchers and research users to co-develop research that can have direct impacts on people, including patients, health practitioners and policy makers.

Supports teams of researchers and research users to disseminate research evidence with those who can directly benefit from it in order to impact health and care in BC.

Registration Open | 23rd Annual Healthcare Summit: The Future of Innovation, Personalized Medicine and Genomics

Registration is now open for the 23rd Annual Healthcare Summit: The Future of Innovation, Personalized Medicine and Genomics

2-4 October 2023 | Vancouver, BC

Educating and discussing the most relevant topics on the rapid acceleration towards digital healthcare:

  • Digital Health Transformations
  • Personalized Medicine
  • Value-Based Healthcare
  • The Future of Pharmacies
  • Artificial Intelligence
  • Genomics
  • Primary Care
  • Digital Health
  • Health Innovation
  • Mental Health

Early Bird Registration Deadline: 15 August 2023 (also listed on ATM Calendar)

Registration Costs:

  • Early Bird
    • Private Sector: $475.00 CAD (plus GST)
    • Public Sector: $775.00 CAD (plus GST)
  • Regular
    • Private Sector: $675.00 CAD (plus GST)
    • Public Sector: $975.00 CAD (plus GST)

Find all information and register here

Find the associated ATM Calendar event here

ATM ECR Congratulations

Please join us in congratulating the following ATM-associated Early Career Researchers (ECRs) for some of their many recent 2023 awards and achievements!


Urology Care Foundation 2022 Rising Stars in Urology Research Award

Dr. Ryan Flannigan

 

2023 UBC Department of Medicine Faculty & Staff Awards

Dr. Zackary Lacksman

      • Award: St. Paul’s Hospital Faculty Research Award
      • In recognition of outstanding research and scholarly contributions.

 

Health Research BC 2022 Health Professional-Investigator (HP-I) Award

Dr. Khaled Abdelrahman

Dr. Emily Brigham

Dr. Yvette Drew

 

New Frontiers in Research Fund (NFRF) Grant

Dr. Anna Blakney

 

CIHR Spring 2023 Project Grant Competition

Dr. Anna Blakney

Dr. Emily Brigham

Dr. Laura Evgin

Dr. Ramon Klein Geltink

Dr. Jonathan Loree

 

Other CIHR 2023 Funding

Dr. Emily Brigham

Dr. Anna Blakney

Dr. Devon Greyson

Dr. Veena Sriram


For more information about the ATM ECRs, please visit our Community page.

Call for Proposals: BC Diabetes Research Network | Type 2 Diabetes Spark Innovation Challenge

Call for Proposals: BC Diabetes Research Network

Type 2 Diabetes Spark Innovation Challenge

Do you have an idea with potential to spark change for British Columbians living with Type 2 diabetes?

Type 2 Diabetes Spark Innovation Challenge is a research competition to spark innovation, collaboration and change in approach to Type 2 Diabetes.

Presented by UBC and supported by Boehringer Ingelheim (BI) the Type 2 Diabetes Spark Innovation Challenge is an opportunity for new or existing partners to look at the challenge of type 2 diabetes and design innovative solutions for type 2 diabetes prevention, management, and remission.

Successful proposals will be invited to present at a special event on September 20th in Kelowna BC. All researchers, clinicians, trainees, staff and community partners are welcome to attend- registration is free.


Funding Opportunity: Type 2 Diabetes Spark Innovation Challenge

Submission Deadline: 6 September 2023

Funding Available: $25,000. One grand prize of $15,000 and one runner-up prize of $10,000 from teams that have an innovative idea, product, or concept in the areas of prevention, treatment, or reversal of type 2 diabetes and its complications.

Award Term: 1 year, non-renewable

Event Registration Deadline: 14 September 2023

Event Registration Cost: Free

Event and Presentation: 20 September 2023 | Kelowna, BC


T2D Spark Event Landing Page: https://event.fourwaves.com/t2dspark

Proposal Submission Link: https://event.fourwaves.com/t2dspark/submission

Registration Link: https://event.fourwaves.com/t2dspark/registration

For additional questions, please contact the BC Diabetes Research Network: info@diabetesbc.ca.

Registration for Entrepreneurship Immersion Week is LIVE!

entrepreneurship@UBC’s biggest event of the year is back for the 4th annual Immersion Week  (eIW)!

Climate and the Public Health Crisis: Systems Changes and Actions Needed

26-28 September 2023 | UBC Robson Square/Point Grey

Entrepreneurship Immersion Week (EIW) brings together storytellers and movement builders from across our ecosystem, to share their insights on the strategies and tactics that helped them transform their ideas to impact.

Entrepreneurship Immersion Week is for the UBC community of students, staff faculty and alumni as well as our community of ventures, mentors, and BC’s innovation ecosystem at large. Each year, it gets bigger and better and can’t wait to see what’s in store for 2023.

Read full details about eIW and the 2023 speakers

Register today!

Jonathan Loree

Dr. Jonathan Loree

Title, Department, and Affiliations:

ATM Leadership Position: Community Representative on the ATM Education Council

Assistant Professor, Department of Medicine, Division of Medical Oncology, UBC

GI Medical Oncologist, BC Cancer

Colon Cancer Disease Site Co-Chair, Canadian Cancer Trials Group

Location: BC Cancer – Vancouver Centre

Tell us about your research and what makes you passionate about it.

Our research group focusses on identifying biomarkers and new treatments to personalize therapy for patients with gastrointestinal cancers. A major focus is on circulating tumor DNA (ctDNA) which can identify mutations from cancers cells in the blood of patients with cancer. ctDNA can be used to screen for cancer in patients without a known cancer, to identify patients at increased risk of having their cancer return after surgery or to personalize treatment for patients receiving systemic therapy.

Is there a translational aspect of your research that you are most excited about?

I get excited by the iterative process of moving from the bench to the bedside and back to the bench again. This allows me to interact with multidisciplinary teams of oncologists, surgeons, scientists, biostatisticians, bioinformaticians, trialists and patients as we try to identify new treatment approaches. If things don’t work, we move back to the lab and try to find out why so we can bring a better approach back to the clinic to evaluate. It let’s me interact with a diverse group of people at each stage of the journey and I’m continually learning new things.

Are there any initiatives you would like to see at UBC to accelerate translational medicine in your area of research?

We learn from and are inspired by the work of others. The pandemic amplified the separation between basic science, translational and clinical researchers. Efforts to cross-pollinate across streams of research and to integrate clinical research into The University of British Columbia will be helpful so that this cross pollination can occur now that research groups are returning to more in-person activities. The ATM is a great venue for this and I look forward to meeting new people through their activities.

You are part of the Academy of Translational Medicine Early Career Researcher cohort at UBC. What is the most important aspect of that community for you?

Community. We are often isolated from others outside of our department or division and may not know what others are doing. The opportunity to meet with others who are interested in translational research but have different ideas and techniques to address questions is invaluable.

Is there a resource that you found impactful and would recommend to others interested in translational medicine?

The “resources” section of the ATM website is a fantastic place to learn about core facilities available in the region.

How do you like to recharge outside of work?

The outdoors. Vancouver and the surrounding regions provide tremendous recreational opportunities to recharge your battery.

Is there anything else you’d like to add?

I’m always looking to meet new collaborators, so if there is anyone interested in working together, please reach out.

CIHR Fall 2023 Project Grant: Updates & Opportunities

CIHR has launched the 2023 Project Grant Competition

About

The Project Grant program is designed to capture ideas with the greatest potential for important advances in fundamental or applied health-related knowledge, health care, health systems, and/or health outcomes by supporting projects of research proposed and conducted by individual researchers or groups of researchers in all areas of health.

The competition encourages applicants to take novel approaches at issues to collectively promote innovative research across the country, and the program aligns well with translational medicine initiatives.The Project Grant program is expected to:

    • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
    • Promote relevant collaborations across disciplines, professions, and sectors; and
    • Contribute to the creation and use of health-related knowledge.

The areas of The Project Grant program is open to applicants in all areas of health research that are aligned with the CIHR mandate, including the important research areas listed below:

    • Global Health
    • Indigenous Health Research
    • Randomized Controlled Trials
    • Commercialization
    • Interdisciplinary research
    • Specific Research Areas

Funding is variable, however a proportion of grants funded will be least equal to the proportion of applications submitted by certain groups such as early career researchers (ECRs) and  female applicants through a reserved portion of the budget.

Webinar: 27 August 2023 | 10am-11am PT (1pm-2pm ET)

Registration Deadline: 17 August 2023

Application Deadline: 15 September 2023

Anticipated Notice of Decision: 31 January 2024

Funding Start Date: 1 April 2024

Full information on the Project Grant competition can be found here

UBC Support

As a reminder, UBC Support Programs to Advance Research Capacity (SPARC) has a plethora of relevant and information and comprehensive support related to the CIHR Project Grant. UBC faculty researchers, especially new faculty are encouraged to utilize SPARC’s services.

Visit here for full details

Early Career Researcher (ECR) Opportunity: Reviewer in Training (RiT) Program

The CIHR has expanded the RiT program to now be open to ECRs. In the RiT program, ECRS are offered an opportunity where they are able to learn about the peer review process and gain a better understanding as to the components in a high-quality review.

Full details for the RiT Program can be found here

Introducing: Translational Medicine Office Hours

Introducing: Translational Medicine Office Hours

First Session: Wednesday 26 July 2023 | 1:30-2:30 PM

Get instant insight on how to drive your life sciences innovation forward from discovery to clinical application.

Introducing a new collaboration between UBC’s Academy of Translational Medicine (ATM), the Human Health Venture Studio hosted by entrepreneurship@UBC/Sauder School of Business, Creative Destruction Lab Vancouver, UBC’s University-Industry Liaison Office, and UBC’s School of Biomedical Engineering, host of the SBME Propels program.

This is a rare opportunity to connect with advisors from each of these groups in one place at one time to get advice and insight into every aspect of the life sciences innovation process—bringing biomedical discovery from bench to bedside.  Please attend if you need advice on topics such as IP strategy, regulatory affairs, venture formation and business planning, partnerships, contracts, and/or how to move past challenges and roadblocks.  We can connect you with mentors, partners, innovation space, venture programs, sources of capital and experts in technology licensing and IP.  If any aspect of the innovation pathway is unclear, join us during Translational Medicine Office Hours to ask questions and hear how each of us can help move your idea forward.

You can submit questions in advance by emailing translational.medicine@ubc.ca or you can queue up to pose questions during the session.  Either way, it’s an opportunity to get real feedback from real practitioners from across the University.


First Session Meeting Details (see the event on our calendar here):

  • When
    • Wednesday 26 July 2023
    • 1:30-2:30 PM
  • Where
    • Virtually on Zoom
    • Meeting Link: Click here
    • Meeting ID: 673 7600 5341, Passcode: 447084

New Publication from ATM ECR Dr. Jonathan Loree

ATM ECR Dr. Khaled Abdelrahman among winners of 2023 DMCBH Alzheimer Disease Research Grant

We are pleased to share that ATM Early Career Researcher Dr. Khaled Abdelrahman’s project was amongst the 5 winning projects receiving funding through the 2023 Djavad Mowafaghian Centre for Brain Health Alzheimer Disease Research Grant.

The project, led by Dr. Abdelrahman and Dr. Brian MacVicar, is titled The contribution of metabotropic glutamate receptor 5 (mGluR5) to impaired neurovascular coupling in Alzheimer disease, described below:

Metabotropic glutamate receptor 5 (mGluR5) is a type of protein found in the brain that plays an important role in controlling how brain cells communicate and form memories. In Alzheimer disease, amyloid-beta (Aβ42) builds up in the brain and causes damage, disrupting the normal functioning of mGluR5 in astrocytes, which are brain cells that play a key role in cerebral blood flow.
The research team has shown that when they block or reduce the activity of mGluR5, it can lead to improvements in memory and brain pathology in mice with Alzheimer disease. This suggests that targeting mGluR5 could be a promising approach to reverse some of the harmful effects triggered by Aβ42 in the brains of people with Alzheimer disease.
The goal of this project is to understand how Aβ42 affects mGluR5 signaling in astrocytes of male and female mice. The research team aims to find out if the changes in mGluR5 signaling contribute to problems with blood flow in the brain and cognitive function in both male and female mice with Alzheimer disease, and whether this is regulated by sex hormones.

We look forward to sharing the promising findings of this project with the ATM community, alongside the findings of the other winning projects.

Learn about the other 4 winning projects here